Determination of trans-resveratrol and its metabolites in rat serum using liquid chromatography with high-resolution time of flight mass spectrometry.

[1]  J. Espinoza,et al.  Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence , 2016, Oncotarget.

[2]  J. Pezzuto,et al.  The pharmacology of resveratrol in animals and humans. , 2015, Biochimica et biophysica acta.

[3]  L. Calani,et al.  Bioaccumulation of resveratrol metabolites in myocardial tissue is dose-time dependent and related to cardiac hemodynamics in diabetic rats. , 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[4]  E. Sauter,et al.  Determination of Celecoxib in human plasma using liquid chromatography with high resolution time of flight-mass spectrometry. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  T. Ichiyanagi,et al.  Absorption and metabolism of piceatannol in rats. , 2014, Journal of agricultural and food chemistry.

[6]  E. Sauter,et al.  Methylation and miRNA Effects of Resveratrol on Mammary Tumors vs. Normal Tissue , 2014, Nutrition and cancer.

[7]  D. Corella,et al.  Gut and microbial resveratrol metabolite profiling after moderate long-term consumption of red wine versus dealcoholized red wine in humans by an optimized ultra-high-pressure liquid chromatography tandem mass spectrometry method. , 2012, Journal of chromatography. A.

[8]  M. Urpi-Sardà,et al.  Pharmacokinetics of resveratrol metabolic profile in healthy humans after moderate consumption of red wine and grape extract tablets. , 2012, Pharmacological research.

[9]  S. Nagar,et al.  Analytical method development for synthesized conjugated metabolites of trans-resveratrol, and application to pharmacokinetic studies. , 2012, Journal of pharmaceutical and biomedical analysis.

[10]  I. Kapetanovic,et al.  Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC-MS/MS and their pharmacokinetics in dogs. , 2012, Journal of pharmaceutical and biomedical analysis.

[11]  A. Novikov,et al.  Practical Preparation of Resveratrol 3-O-β-D-Glucuronide , 2012, Synthetic communications.

[12]  T. Kapoor,et al.  Examining the mechanism of action of a kinesin inhibitor using stable isotope labeled inhibitors for cross-linking (SILIC). , 2011, Journal of the American Chemical Society.

[13]  H. Mukhtar,et al.  Enhancing the bioavailability of resveratrol by combining it with piperine. , 2011, Molecular nutrition & food research.

[14]  M. Garcia-Conesa,et al.  Metabolites and tissue distribution of resveratrol in the pig. , 2011, Molecular nutrition & food research.

[15]  Bin Di,et al.  Rapid, Sensitive and Selective Analysis of trans-Resveratrol in Rat Plasma by LC–MS–MS , 2011 .

[16]  I. Kapetanovic,et al.  Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats , 2011, Cancer Chemotherapy and Pharmacology.

[17]  M. Garcia-Conesa,et al.  Pharmacokinetic study of trans-resveratrol in adult pigs. , 2010, Journal of agricultural and food chemistry.

[18]  J. Pezzuto,et al.  Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites. , 2010, Journal of medicinal chemistry.

[19]  Q. Wang,et al.  Identification of metabolic pattern and bioactive form of resveratrol in human medulloblastoma cells. , 2010, Biochemical pharmacology.

[20]  Meng-lei Huan,et al.  High Performance Liquid Chromatography—Tandem Mass Spectrometric Determination of Resveratrol and Its Metabolites in Rat Tissues , 2010 .

[21]  J. Planas,et al.  Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC. , 2010, Journal of pharmaceutical and biomedical analysis.

[22]  A. Falcão,et al.  Pharmacokinetics of Trans‐resveratrol Following Repeated Administration in Healthy Elderly and Young Subjects , 2009, Journal of clinical pharmacology.

[23]  X. Zhang,et al.  Dose-dependent absorption and metabolism of trans-polydatin in rats. , 2009, Journal of agricultural and food chemistry.

[24]  V. Fogliano,et al.  Dietary trans‐resveratrol bioavailability and effect on CCl4‐induced liver lipid peroxidation , 2009, Journal of gastroenterology and hepatology.

[25]  A. Arend,et al.  trans‐resveratrol alone and hydroxystilbenes of rhubarb (Rheum rhaponticum L.) root reduce liver damage induced by chronic ethanol administration: a comparative study in mice , 2009, Phytotherapy research : PTR.

[26]  Donggeng Wang,et al.  Tissue distribution and excretion of resveratrol in rat after oral administration of Polygonum cuspidatum extract (PCE). , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[27]  V. Somoza,et al.  Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O-conjugated diglucuronides - two novel resveratrol metabolites in human plasma. , 2008, Molecular nutrition & food research.

[28]  J. Crowell,et al.  Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[29]  Joseph A. Baur,et al.  Therapeutic potential of resveratrol: the in vivo evidence , 2006, Nature Reviews Drug Discovery.

[30]  Chunyong Wu,et al.  Identification of the major metabolites of resveratrol in rat urine by HPLC-MS/MS. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[31]  V. Somoza,et al.  Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. , 2005, Molecular nutrition & food research.

[32]  R. Marchelli,et al.  Bioavailability of trans-resveratrol from red wine in humans. , 2005, Molecular nutrition & food research.

[33]  P. Maliakal,et al.  Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. , 2004, Journal of agricultural and food chemistry.

[34]  J. Pezzuto,et al.  Human, Rat, and Mouse Metabolism of Resveratrol , 2002, Pharmaceutical Research.

[35]  J. Marier,et al.  Metabolism and Disposition of Resveratrol in Rats: Extent of Absorption, Glucuronidation, and Enterohepatic Recirculation Evidenced by a Linked-Rat Model , 2002, Journal of Pharmacology and Experimental Therapeutics.

[36]  J. Shull,et al.  Ovary-intact, but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma. , 1997, Carcinogenesis.